Volume-adjusted p2PSA-derived indices for predicting prostate cancer: the PROPHET study
International Journal of Clinical Oncology · 2026-08 · 31 (8) · 1567-1575
DOI: 10.1007/s10147-026-03063-6 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Clinical Oncology, online erschienen am 09.06.2026. Verfasst von Masaki Shiota und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan. shiota.masaki.10…. Hauptthemen laut MEDLINE: Prostate, Prostate-Specific Antigen, Prostatic Neoplasms. Die Arbeit nennt 16 Literaturangaben. Gefördert von: Beckman Coulter, Inc..
Abstract (Originalsprache)
BACKGROUND: This study aimed to assess the diagnostic value of prostate and transition zone (TZ) volume-adjusted p2PSA-derived indices for detecting any and clinically significant prostate cancer (PCa) in the prospective multicenter PROPHET study. METHODS: Among 363 men (median age 68 years, PSA 5.96 ng/mL), total PSA, free PSA, and p2PSA were measured to calculate %p2PSA, p2PSA/%fPSA, and the Prostate Health Index (PHI). Each index was adjusted by prostate or TZ volume. Diagnostic accuracy for any PCa and clinically significant PCa (csPCa) was evaluated using the area under the receiver operating characteristic curve (AUC), partial AUC (> 90% sensitivity), specificity, positive predictive value, negative predictive value, and false-positive rate. RESULTS: PCa was detected in 179 men (49.3%). For predicting any PCa, PHI density and TZ volume-adjusted PHI showed AUCs of 0.797 and 0.788 with false-positive rates of 50.5%. For csPCa defined as > 2 positive cores or Gleason Grade Group ≥ 2-3, AUCs were 0.807-0.823 and false-positive rates 42.0-47.5%. Both indices enabled biopsy avoidance in 49-58% of men without csPCa while maintaining 90% sensitivity. The diagnostic performance of PHI density and TZ volume-adjusted PHI was statistically superior to PSA density and TZ volume-adjusted PSA, demonstrating improved discriminative ability at key clinical thresholds. CONCLUSION: Volume-adjusted p2PSA-derived indices demonstrated improved diagnostic performance and may reduce unnecessary biopsies. Their validation in a PHI-independent prospective design supports robust clinical applicability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan. shiota.masaki.101@m.kyushu-u.ac.jp.
- Department of Urology, Graduate School of Medicine, Gunma University, Maebashi, Japan.
- Clinical Therapeutic Trial Center, Ehime University Hospital, Toon, Japan.
- Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan.
- Department of Urology, Hara-Sanshin Hospital, Fukuoka, Japan.
- Institute for Preventive Medicine, Kurosawa Hospital, Takasaki, Japan.
Förderung
- Beckman Coulter, Inc.
Zitieren
APA
Shiota, M., Sekine, Y., Tokunaga, S., Yokomizo, A., Ito, K., Arai, G., Sugimoto, M., Kito, H., Hasumi, H., Sakai, H., Kobori, Y., Kato, T., Nakada, T., Ito, Y., Hakariya, T., Eto, M., & Suzuki, K. (2026). Volume-adjusted p2PSA-derived indices for predicting prostate cancer: the PROPHET study. International Journal of Clinical Oncology, 31(8), 1567-1575. https://doi.org/10.1007/s10147-026-03063-6
Vancouver
Shiota M, Sekine Y, Tokunaga S, Yokomizo A, Ito K, Arai G, et al. Volume-adjusted p2PSA-derived indices for predicting prostate cancer: the PROPHET study. International Journal of Clinical Oncology. 2026;31(8):1567-1575. doi:10.1007/s10147-026-03063-6
BibTeX
@article{Shiota2026,
author = {Shiota, Masaki and Sekine, Yoshitaka and Tokunaga, Shoji and Yokomizo, Akira and Ito, Kazuto and Arai, Gaku and Sugimoto, Mikio and Kito, Hiroki and Hasumi, Hisashi and Sakai, Hideki and Kobori, Yoshitomo and Kato, Takuma and Nakada, Takako and Ito, Yusuke and Hakariya, Tomoaki and Eto, Masatoshi and Suzuki, Kazuhiro},
title = {Volume-adjusted p2PSA-derived indices for predicting prostate cancer: the PROPHET study},
journal = {International Journal of Clinical Oncology},
year = {2026},
volume = {31},
number = {8},
pages = {1567--1575},
doi = {10.1007/s10147-026-03063-6}
}
EUVIMED